FDA Advisory Panel Recommends Heightened Warnings On Commonly Prescribed Antibiotics.

reports that an advisory panel for the Food and Drug Administration called for greater label warnings for the side effects of fluoroquinolones. The panel voted 21-0 on sinusitis, 18-2 on bronchitis, and 20-1 on urinary-tract infections. http://www.wsj.com/articles/fda-panel-seeks-tougher-antibiotic-labels-1446784061?mod=rss_US_News